findmyKOL
Clinical trialNCT07223840RecruitingPhase 2Interventional

A Study of Brenipatide in Adults Who Quit Smoking Cigarettes and Want to Avoid Relapse

SponsorEli Lilly and CompanyEnrollment222Smoking
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST)

    Eli Lilly and Company

    Study Director

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

27 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

China
  • Beijing Anding Hospital - Affiliated Capital University of Medical Science

    Beijing, China

    Anning Li
    Recruiting
  • Beijing Chaoyang Hospital, Capital Medical University

    Beijing, China

    Lirong Liang
    Recruiting
  • Sichuan Provincial People'S Hospital

    Chengdu, China

    Haiying Yan
    Recruiting
  • 2nd Affiliated Hospital Chongqing Medical University

    Chongqing, China

    Na Li
    Recruiting
  • Sir Run Run Shaw Hospital of Zhejiang University School of Medicine

    Hangzhou, China

    Jinsong Tang
    Recruiting
  • Taizhou Hospital of Zhejiang Province

    Linhai, China

    Dongqing LV
    Recruiting
  • the First Affiliated Hospital of Ningbo University

    Ningbo, China

    Yunxin Ji
    Recruiting
  • the University of Hong Kong-Shenzhen Hospital

    Shenzhen, China

    Lei Rong
    Recruiting
Japan
  • Miyazaki Rc Clinic

    Shinagawa-ku, Japan

    Masaki Miyazaki
    Recruiting
  • Samoncho Clinic

    Shinjuku, Japan

    Takahiro Yokoyama
    Recruiting
  • Higashi Shinjuku Clinic

    Tokyo, Japan

    Hiroaki Kondo
    Recruiting
United States
  • Woodland Research Northwest

    Rogers, Arkansas, United States

    Timothy Cook
    Recruiting
  • Hillcrest Medical Research

    DeLand, Florida, United States

    Active, not recruiting
  • Tectum Research

    Hollywood, Florida, United States

    Juan Rondon
    Recruiting
  • K2 Medical Research Orlando

    Maitland, Florida, United States

    Brandon Lenox
    Recruiting
  • Gtl Medical & Research Group

    Miami, Florida, United States

    Dunia Llapur Hernandez
    Recruiting
  • North Georgia Clinical Research

    Woodstock, Georgia, United States

    Bram Wieskopf
    Recruiting
  • Revival Research Institute, Llc

    Dearborn, Michigan, United States

    Abdulhassan Saad
    Recruiting
  • Arch Clinical Trials

    St Louis, Missouri, United States

    Kulsoom Junaid
    Recruiting
  • Vector Clinical Trials

    Las Vegas, Nevada, United States

    Ann Childress
    Recruiting
  • Rochester Clinical Research, Llc

    Rochester, New York, United States

    Leigh Schirmer
    Recruiting
  • Coastal Carolina Research Center

    North Charleston, South Carolina, United States

    Rica Santiago
    Recruiting
  • Circle Clinical Research

    Sioux Falls, South Dakota, United States

    Sophie Two Hawk
    Recruiting
  • Futuresearch Trials of Dallas

    Dallas, Texas, United States

    Michael Downing
    Recruiting
  • the University of Texas Health Science Center at Houston

    Houston, Texas, United States

    Luba Yammine
    Recruiting
  • Health Research of Hampton Roads, Inc.

    Newport News, Virginia, United States

    George Freeman
    Recruiting
  • Eastside Research Associates

    Redmond, Washington, United States

    Chad Crystal
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
3 Nov 2025
Primary completion
28 Feb 2027
Completion
28 Feb 2027
Last update posted
12 Jun 2026
Registered enrollment
222
Registry id
NCT07223840

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.